GT Biopharma, Inc. (GTBP) at a glance

GT Biopharma, Inc. (GTBP) is a micro-cap Healthcare company. It trades at $0.44, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 51/100 overall. Its strongest dimension is Safety (80/100) and its weakest is Momentum (16/100). Its volatility is roughly in line with the market.

Price

$0.44

Market cap

$16.1M

P/E ratio

n/a

Dividend yield

None

Beta

0.86

52-week range

$0.26 to $3.85